Pharmaceutical Contract Manufacturing Market Report 2026-2036

The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 7.9% by 2036

SKU: PHA1388 Categories: Contract Services, Popular Reports Code: PHA1388Pages: 419

Download Sample Form

"*" indicates required fields

Name*

Company*

Designation*

Job Title

Industry

Email*

Phone*

Address*

This field is hidden when viewing the form

Report Title

This field is hidden when viewing the form

Sample url

← Back to category Contract Services

Description

The Pharmaceutical Contract Manufacturing Market Report 2026-2036 provides a comprehensive analysis of market size, growth drivers, competitive positioning, and revenue forecasts across key segments and regions.

The global pharmaceutical contract manufacturing market is expected to grow from US$171.00 billion in 2026 to US$367.06 billion by 2036, at a CAGR of 7.9% over the forecast period. Growth is supported by sustained investment in pharmaceutical R&D, increasing outsourcing to contract development and manufacturing organisations (CDMOs), and rising demand for complex biologics and advanced therapies.

Access a Free Sample of This Report

Download a sample to explore:

Market forecasts and segment breakdowns
Competitive and company-level insights
Key trends shaping the market
Trade, policy, and supply chain analysis

Technological and R&D Investment Driving Market Expansion

Increasing investment in pharmaceutical research and development is a key structural driver of demand for contract manufacturing. As pipelines expand across small molecules, biologics, and advanced modalities such as antibody-drug conjugates and peptides, pharmaceutical companies are increasingly relying on CDMOs for specialised capabilities, scalability, and speed to market.

This shift enables more efficient capital allocation while supporting faster development timelines and flexible production across clinical and commercial stages. Continued innovation in biologics manufacturing and process development is further strengthening the role of outsourcing in the global pharmaceutical value chain.

Trade, Policy and Supply Chain Dynamics

US trade tariffs are expected to influence the pharmaceutical contract manufacturing market by reshaping global supply chains and increasing the importance of localised production. Tariffs on imported pharmaceuticals may increase cost pressures on cross-border manufacturing models, prompting companies to prioritise domestic or regionally aligned production strategies.

In response, CDMOs with multi-regional manufacturing networks and integrated service capabilities are expected to strengthen their competitive position. Demand is likely to shift towards partners that offer supply chain resilience, regulatory alignment, and operational flexibility.

Commercial Impact

Cost and pricing pressure: Tariffs and regulatory requirements are increasing manufacturing costs
Supply chain shifts: Companies are diversifying sourcing and investing in regional production capacity
Regulatory influence: Compliance requirements continue to shape market access and timelines
Competitive positioning: CDMOs with global infrastructure and advanced capabilities are better positioned

Company Intelligence

The pharmaceutical contract manufacturing market is highly competitive, with a mix of global CDMOs, specialised providers, and integrated pharmaceutical companies competing across capability, scale, and geographic reach.

Leading companies including AbbVie Inc., Lonza, Thermo Fisher Scientific Inc., Samsung Biologics, and WuXi AppTec are strengthening their market positions through capacity expansion, technology investment, and strategic partnerships.

Competition is increasingly defined by:

Technology capability and specialisation
Regulatory expertise and compliance
Global manufacturing footprint
Ability to support complex and biologics-based production

At the same time, emerging players and regional CDMOs are gaining traction where cost efficiency, niche expertise, or local presence create differentiation.

Key Questions Answered

How is the pharmaceutical contract manufacturing market evolving?
What are the key drivers and restraints shaping the market?
How will each segment perform over the forecast period?
Which regions and countries will lead growth?
Who are the leading players and how will their strategies evolve?

Report Scope and Data Coverage

Global pharmaceutical contract manufacturing market analysis
Revenue forecasts to 2036
Segment-level modelling across drug type, services, scale of operation, and end-users
Regional and national market forecasts
Competitive intelligence on leading companies

Segmentation Framework

By Drug Type

Branded
Generics

By Services

Pharmaceutical Manufacturing Services
– Pharmaceutical API Manufacturing Services
– Pharmaceutical FDF Manufacturing Services
Drug Development Services
– Lead Identification and Candidate Optimisation
– Target Identification and Screening
– Target Validation and Functional Informatics
– Other Services
Biologics Manufacturing Services
– Biologics API Manufacturing Services
– Biologics FDF Manufacturing Services

By Scale of Operation

Clinical
Commercial

By End-users

Big Pharmaceutical Companies
Small and Medium-sized Pharmaceutical Companies
Generic Pharmaceutical Companies
Others

Geographic Coverage

North America

U.S.
Canada

Europe

Germany
UK
France
Italy
Spain
Rest of Europe

Asia Pacific

Japan
China
India
Australia
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East and Africa

GCC
South Africa
Rest of MEA

Need industry data? Please contact us today.

Why This Market Intelligence Matters

The pharmaceutical contract manufacturing market is evolving rapidly as outsourcing becomes central to pharmaceutical development and production strategies. Organisations that understand these dynamics will be better positioned to capture growth opportunities, optimise supply chains, and strengthen competitive positioning.

Access the Full Forecast and Competitive Analysis

Purchase the Pharmaceutical Contract Manufacturing Market Report 2026-2036 to access the complete dataset, forecasts, and competitive analysis.

Download sample or contact us for enterprise access

For enterprise licensing, customised segmentation or analyst briefings, contact Visiongain directly at contactus@visiongain.com

Government Registration
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharmaceutical Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Patent Expiry and Increasing Demand for Generic Drugs
3.3.1.2 Increasing Investments in Pharmaceutical R&D
3.3.1.3 Investments in Advanced Manufacturing Technologies by CDMOs
3.3.1.4 Increasing Venture-Capital Funded Virtual Biotech
3.3.1.5 Accelerating Small and Mid-sized Pharma Outsourcing
3.3.2 Market Restraining Factors
3.3.2.1 Supply Chain Vulnerabilities
3.3.2.2 Varying Regulatory Scenarios
3.3.2.3 High Capital Investment Requirements in Pharmaceutical Manufacturing
3.3.3 Market Opportunities
3.3.3.1 Increasing Demand for Biological Therapies
3.3.3.2 Growth in the Nuclear Medicine Sector
3.3.3.3 Growing Demand for Cell and Gene Therapies
3.3.3.4 Growth Opportunities in Emerging Countries
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of New Entrants
3.4.4 Threat of Substitutes
3.4.5 Competitive Rivalry
3.5 PEST Analysis
3.6 U.S. Tariffs: What’s the Impact on Global Pharmaceutical Contract Manufacturing Market?
3.6.1 Overview
3.6.2 V-Shaped Recovery Scenario
3.6.3 Why V-Shaped Recovery?
3.6.3.1 Impact from Tariffs
3.6.3.2 Market Dynamics and Demand Recovery
3.6.3.3 Policy and Funding Support
3.6.3.4 Timeframe for Recovery
3.6.4 U-Shaped Recovery Scenario
3.6.4.1 Why U-Shaped Recovery?
3.6.4.2 Impact from Tariffs
3.6.4.3 Market Dynamics and Demand Recovery
3.6.4.4 Policy and Funding Support
3.6.4.5 Timeframe for Recovery
3.6.5 L Shaped Recovery Scenario
3.6.5.1 Why L-Shaped Recovery?
3.6.5.2 Impact from Tariffs
3.6.5.3 Market Dynamics and Demand Recovery
3.6.5.4 Policy and Funding Support
3.6.5.5 Timeframe for Recovery
3.6.6 What Strategic Considerations Should Clients Factor into Their Near-term (2026–2031) and Long-term (2026–2036) Planning?
3.6.7 Impact of U.S. and China Trade War on Pharmaceutical Contract Manufacturing Market
3.6.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?

4 Pharmaceutical Contract Manufacturing Market Analysis by Drug Type
4.1 Key Findings
4.2 Drug Type Segment: Market Attractiveness Index
4.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
4.4 Branded
4.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2026 & 2036 (%)
4.5 Generics
4.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2026 & 2036 (%)

5 Pharmaceutical Contract Manufacturing Market Analysis by Services
5.1 Key Findings
5.2 Services Segment: Market Attractiveness Index
5.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
5.4 Pharmaceutical Manufacturing Services
5.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2026 & 2036 (%)
5.4.3 Pharmaceutical Manufacturing Services Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
5.4.4 Pharmaceutical API Manufacturing Services
5.4.5 Pharmaceutical FDF Manufacturing Services
5.5 Drug Development Services
5.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2026 & 2036 (%)
5.5.3 Drug Development Services Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
5.5.4 Lead Identification and Candidate Optimization
5.5.5 Target Identification and Screening
5.5.6 Target Validation and Functional Informatics
5.5.7 Other Services
5.6 Biologics Manufacturing Services
5.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2026 & 2036 (%)
5.6.3 Biologics Manufacturing Services Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
5.6.4 Biologics API Manufacturing Services
5.6.5 Biologics FDF Manufacturing Services

6 Pharmaceutical Contract Manufacturing Market Analysis by Scale of Operation
6.1 Key Findings
6.2 Scale of Operation Segment: Market Attractiveness Index
6.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
6.4 Clinical
6.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Commercial
6.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2026 & 2036 (%)

7 Pharmaceutical Contract Manufacturing Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
7.4 Big Pharmaceutical Companies
7.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Small & Medium-sized Pharmaceutical Companies
7.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2026 & 2036 (%)
7.6 Generic Pharmaceutical Companies
7.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.6.2 Market Share by Region, 2026 & 2036 (%)
7.7 Others
7.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.7.2 Market Share by Region, 2026 & 2036 (%)

8 Pharmaceutical Contract Manufacturing Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Pharmaceutical Contract Manufacturing Market Analysis
9.1 Key Findings
9.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
9.3 North America Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
9.4 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
9.5 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
9.6 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
9.7 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
9.8 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
9.9 U.S. Pharmaceutical Contract Manufacturing Market Analysis
9.10 Canada Pharmaceutical Contract Manufacturing Market Analysis

10 Europe Pharmaceutical Contract Manufacturing Market Analysis
10.1 Key Findings
10.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
10.3 Europe Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
10.4 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
10.5 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
10.6 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
10.7 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
10.8 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
10.9 Germany Pharmaceutical Contract Manufacturing Market Analysis
10.10 UK Pharmaceutical Contract Manufacturing Market Analysis
10.11 France Pharmaceutical Contract Manufacturing Market Analysis
10.12 Italy Pharmaceutical Contract Manufacturing Market Analysis
10.13 Spain Pharmaceutical Contract Manufacturing Market Analysis
10.14 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis

11 Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
11.1 Key Findings
11.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
11.3 Asia Pacific Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
11.4 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
11.5 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
11.6 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
11.7 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
11.8 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
11.9 Japan Pharmaceutical Contract Manufacturing Market Analysis
11.10 China Pharmaceutical Contract Manufacturing Market Analysis
11.11 India Pharmaceutical Contract Manufacturing Market Analysis
11.12 Australia Pharmaceutical Contract Manufacturing Market Analysis
11.13 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis

12 Latin America Pharmaceutical Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
12.3 Latin America Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
12.4 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
12.5 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
12.6 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
12.7 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
12.8 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
12.9 Brazil Pharmaceutical Contract Manufacturing Market Analysis
12.10 Mexico Pharmaceutical Contract Manufacturing Market Analysis
12.11 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis

13 MEA Pharmaceutical Contract Manufacturing Market Analysis
13.1 Key Findings
13.2 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
13.3 MEA Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
13.4 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
13.5 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
13.6 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
13.7 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
13.8 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
13.9 GCC Pharmaceutical Contract Manufacturing Market Analysis
13.10 South Africa Pharmaceutical Contract Manufacturing Market Analysis
13.11 Rest of MEA Pharmaceutical Contract Manufacturing Market Analysis

14 Company Profiles
14.1 Competitive Landscape
14.2 Strategic Outlook
14.3 Lonza
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2021-2025
14.3.3.2 R&D, 2021-2025
14.3.3.3 Regional Market Shares, 2025
14.3.3.4 Business Segment Market Shares, 2025
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.4 Catalent, Inc. (A Novo Holdings Company)
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2021-2024
14.4.3.2 Regional Market Shares, 2024
14.4.3.3 Business Segment Market Shares, 2024
14.4.4 Service Benchmarking
14.4.5 Strategic Outlook
14.5 Recipharm AB
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Service Benchmarking
14.5.4 Strategic Outlook
14.6 AbbVie Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2021-2025
14.6.3.2 R&D, 2021-2025
14.6.3.3 Regional Market Shares, 2025
14.6.3.4 Business Segment Market Shares, 2025
14.6.4 Service Benchmarking
14.7 Thermo Fisher Scientific Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2021-2025
14.7.3.2 R&D, 2021-2025
14.7.3.3 Regional Market Shares, 2025
14.7.3.4 Business Segment Market Shares, 2025
14.7.4 Service Benchmarking
14.7.5 Strategic Outlook
14.8 Siegfried Holding AG
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2021-2025
14.8.3.2 Regional Market Shares, 2025
14.8.3.3 Business Segment Market Shares, 2025
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 Evonik Industries AG
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2021-2025
14.9.3.2 Regional Market Shares, 2025
14.9.3.3 Business Segment Market Shares, 2025
14.9.4 Service Benchmarking
14.9.5 Strategic Outlook
14.10 Boehringer Ingelheim International GmbH
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2021-2025
14.10.3.2 R&D, 2021-2025
14.10.3.3 Regional Market Shares, 2025
14.10.3.4 Business Segment Market Shares, 2025
14.10.4 Service Benchmarking
14.11 Piramal Pharma Solutions
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2021-2025
14.11.3.2 Business Segment Market Shares, 2025
14.11.4 Service Benchmarking
14.11.5 Strategic Outlook
14.12 Samsung Biologics
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2021-2025
14.12.4 Service Benchmarking
14.12.5 Strategic Outlook
14.13 WuXi AppTec
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2021-2025
14.13.3.2 Regional Market Shares, 2025
14.13.3.3 Business Segment Market Shares, 2025
14.13.4 Service Benchmarking
14.13.5 Strategic Outlook
14.14 FUJIFILM Diosynth Biotechnologies
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2021-2024
14.14.3.2 R&D, 2021-2024
14.14.4 Service Benchmarking
14.14.5 Strategic Outlook
14.15 ICON plc
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2021-2024
14.15.3.2 Regional Market Shares, 2024
14.15.4 Service Benchmarking
14.15.5 Strategic Outlook
14.16 Abnova Corporation
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Service Benchmarking
14.16.4 Strategic Outlook
14.17 Vetter Pharma
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Service Benchmarking
14.17.4 Strategic Outlook
14.18 Aenova Group
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.3.1 Net Revenue, 2021-2024
14.18.3.2 Regional Market Shares, 2024
14.18.3.3 Business Segment Market Shares, 2024
14.18.4 Service Benchmarking
14.18.5 Strategic Outlook
14.19 Almac Group
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Service Benchmarking
14.19.4 Strategic Outlook
14.20 Nipro Pharma Corporation
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis
14.20.3.1 Net Revenue, 2021-2025
14.20.3.2 R&D, 2021-2025
14.20.3.3 Regional Market Shares, 2025
14.20.3.4 Business Segment Market Shares, 2025
14.20.4 Service Benchmarking
14.20.5 Strategic Outlook
14.21 Jubilant Pharmova Limited
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Service Benchmarking
14.21.4 Strategic Outlook
14.22 Pfizer Inc.
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Financial Analysis
14.22.3.1 Net Revenue, 2021-2025
14.22.3.2 R&D, 2021-2025
14.22.3.3 Regional Market Shares, 2025
14.22.3.4 Business Segment Market Shares, 2025
14.22.4 Service Benchmarking
14.23 Grifols, S.A.
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Financial Analysis
14.23.3.1 Net Revenue, 2021-2025
14.23.3.2 R&D, 2021-2025
14.23.4 Strategic Outlook
14.24 Charles River Laboratories
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Financial Analysis
14.24.3.1 Net Revenue, 2021-2025
14.24.3.2 Regional Market Shares, 2025
14.24.3.3 Business Segment Market Shares, 2025
14.24.4 Service Benchmarking
14.24.5 Strategic Outlook
14.25 IQVIA Inc.
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Financial Analysis
14.25.3.1 Net Revenue, 2021-2025
14.25.3.2 Regional Market Shares, 2025
14.25.3.3 Business Segment Market Shares, 2025
14.25.4 Service Benchmarking
14.26 Baxter
14.26.1 Company Snapshot
14.26.2 Company Overview
14.26.3 Financial Analysis
14.26.3.1 Net Revenue, 2021-2025
14.26.3.2 R&D, 2021-2025
14.26.3.3 Regional Market Shares, 2025
14.26.3.4 Business Segment Market Shares, 2025
14.26.4 Service Benchmarking
14.27 Curia Global, Inc.
14.27.1 Company Snapshot
14.27.2 Company Overview
14.27.3 Service Benchmarking
14.27.4 Strategic Outlook
14.28 Lannett
14.28.1 Company Snapshot
14.28.2 Company Overview
14.28.3 Service Benchmarking
14.29 Eurofins Scientific
14.29.1 Company Snapshot
14.29.2 Company Overview
14.29.3 Financial Analysis
14.29.3.1 Net Revenue, 2021-2025
14.29.3.2 Regional Market Shares, 2025
14.29.3.3 Business Segment Market Shares, 2025
14.29.4 Service Benchmarking
14.30 IDT Biologika
14.30.1 Company Snapshot
14.30.2 Company Overview
14.30.3 Service Benchmarking
14.30.4 Strategic Outlook
14.31 Cambrex Corporation
14.31.1 Company Snapshot
14.31.2 Company Overview
14.31.3 Service Benchmarking
14.31.4 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Pharmaceutical Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ Billion, CAGR %)
Table 2 Patent Expiry, 2025-2026
Table 3 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 4 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 5 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 7 Branded Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 8 Generics Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 9 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 10 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 11 Pharmaceutical Contract Manufacturing Market Forecast by Pharmaceutical Manufacturing Services, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 12 Drug Development Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 13 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 14 Biologics Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 15 Pharmaceutical Contract Manufacturing Market Forecast by Pharmaceutical Manufacturing Services, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 16 Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 17 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 18 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 19 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 20 Big Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 21 Small & Medium-sized Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 22 Generic Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 23 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 24 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 25 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 26 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 27 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 28 North America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 29 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 30 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 31 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 32 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 37 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 38 UK Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 39 France Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 40 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 41 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 42 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 43 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 44 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 46 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 47 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 48 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 49 China Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 50 India Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 51 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 52 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 53 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 54 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 55 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 57 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 58 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 59 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 60 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 61 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 62 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 63 MEA Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 65 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 66 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 67 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
Table 68 Company Ranking
Table 69 Strategic Outlook
Table 70 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Lonza: Service Benchmarking
Table 72 Lonza: Strategic Outlook
Table 73 Catalent, Inc. (A Novo Holdings Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Catalent, Inc. (A Novo Holdings Company): Service Benchmarking
Table 75 Catalent, Inc. (A Novo Holdings Company): Strategic Outlook
Table 76 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Recipharm AB: Service Benchmarking
Table 78 Recipharm AB: Strategic Outlook
Table 79 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 AbbVie Inc.: Service Benchmarking
Table 81 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 83 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 84 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Siegfried Holding AG: Service Benchmarking
Table 86 Siegfried Holding AG: Strategic Outlook
Table 87 Evonik Industries AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Evonik Industries AG: Service Benchmarking
Table 89 Evonik Industries AG: Strategic Outlook
Table 90 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Boehringer Ingelheim International GmbH: Service Benchmarking
Table 92 Piramal Pharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Piramal Pharma Solutions: Service Benchmarking
Table 94 Piramal Pharma Solutions: Strategic Outlook
Table 95 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Samsung Biologics: Service Benchmarking
Table 97 Samsung Biologics: Strategic Outlook
Table 98 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 WuXi AppTec: Service Benchmarking
Table 100 WuXi AppTec: Strategic Outlook
Table 101 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 103 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 104 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 ICON plc: Service Benchmarking
Table 106 ICON plc: Strategic Outlook
Table 107 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Abnova Corporation: Service Benchmarking
Table 109 Abnova Corporation: Strategic Outlook
Table 110 Vetter Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Vetter Pharma: Service Benchmarking
Table 112 Vetter Pharma: Strategic Outlook
Table 113 Aenova Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Aenova Group: Service Benchmarking
Table 115 Aenova Group: Strategic Outlook
Table 116 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Almac Group: Service Benchmarking
Table 118 Almac Group: Strategic Outlook
Table 119 Nipro Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Nipro Pharma Corporation: Service Benchmarking
Table 121 Nipro Pharma Corporation: Strategic Outlook
Table 122 Jubilant Pharmova Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Jubilant Pharmova Limited: Service Benchmarking
Table 124 Jubilant Pharmova Limited: Strategic Outlook
Table 125 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Pfizer Inc.: Service Benchmarking
Table 127 Grifols, S.A.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Grifols, S.A.: Strategic Outlook
Table 129 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Charles River Laboratories: Service Benchmarking
Table 131 Charles River Laboratories: Strategic Outlook
Table 132 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 IQVIA Inc.: Service Benchmarking
Table 134 Baxter: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 Baxter: Service Benchmarking
Table 136 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Curia Global, Inc.: Service Benchmarking
Table 138 Curia Global, Inc.: Strategic Outlook
Table 139 Lannett: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Lannett: Service Benchmarking
Table 141 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Eurofins Scientific: Service Benchmarking
Table 143 IDT Biologika: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 IDT Biologika: Service Benchmarking
Table 145 IDT Biologika: Strategic Outlook
Table 146 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 Cambrex Corporation: Service Benchmarking
Table 148 Cambrex Corporation: Strategic Outlook

List of Figures
Figure 1 Pharmaceutical Contract Manufacturing Market Segmentation
Figure 2 Pharmaceutical Contract Manufacturing Market by Drug Type: Market Attractiveness Index
Figure 3 Pharmaceutical Contract Manufacturing Market by Services: Market Attractiveness Index
Figure 4 Pharmaceutical Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
Figure 5 Pharmaceutical Contract Manufacturing Market by End-users: Market Attractiveness Index
Figure 6 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Region
Figure 7 Pharmaceutical Contract Manufacturing Market: Market Dynamics
Figure 8 Pharmaceutical Contract Manufacturing Market: Impact Analysis
Figure 9 R&D Expenditure of Major Companies, 2024 & 2025 (US$ Billion)
Figure 10 CDER’s Novel Drug Approvals by Year
Figure 11 Pharmaceutical Contract Manufacturing Market: Porter’s Five Forces Analysis
Figure 12 Pharmaceutical Contract Manufacturing Market: PEST Analysis
Figure 13 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 14 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 15 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 16 Short Term & Long-Term Planning
Figure 17 Impact of U.S. and China Trade War
Figure 18 Most Impacted Countries
Figure 19 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Drug Type
Figure 20 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
Figure 21 Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026, 2031, 2036 (%)
Figure 22 Branded Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 23 Branded Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Generics Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 25 Generics Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Drug Type
Figure 27 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
Figure 28 Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026, 2031, 2036 (%)
Figure 29 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 30 Pharmaceutical Manufacturing Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 31 Pharmaceutical Manufacturing Services Segment Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 32 Drug Development Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 33 Drug Development Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 34 Drug Development Services Segment Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 35 Biologics Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 36 Biologics Manufacturing Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Pharmaceutical Manufacturing Services Segment Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 38 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Scale of Operation
Figure 39 Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
Figure 40 Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026, 2031, 2036 (%)
Figure 41 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 42 Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 43 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 44 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 45 Pharmaceutical Contract Manufacturing Market Attractiveness Index by End-users
Figure 46 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 47 Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026, 2031, 2036 (%)
Figure 48 Big Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 49 Big Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Small & Medium-sized Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 51 Small & Medium-sized Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Generic Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 53 Generic Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 54 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 55 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 56 Pharmaceutical Contract Manufacturing Market Forecast by Region 2026, 2031, 2036 (Revenue, CAGR%)
Figure 57 Pharmaceutical Contract Manufacturing Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 58 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Bn, AGR %)
Figure 59 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 60 North America Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 61 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 62 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 63 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
Figure 64 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
Figure 65 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
Figure 66 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
Figure 67 North America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
Figure 68 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
Figure 69 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 70 North America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 71 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 72 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 73 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 74 Europe Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 75 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 76 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 77 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
Figure 78 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
Figure 79 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
Figure 80 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
Figure 81 Europe Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
Figure 82 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
Figure 83 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 84 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 85 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 86 UK Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 87 France Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 88 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 89 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 90 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 91 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 92 Asia Pacific Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 93 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 94 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 95 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
Figure 96 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
Figure 97 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
Figure 98 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
Figure 99 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
Figure 100 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
Figure 101 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 102 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 103 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 104 China Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 105 India Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 106 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 107 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 108 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 109 Latin America Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 110 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 111 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 112 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
Figure 113 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
Figure 114 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
Figure 115 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
Figure 116 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
Figure 117 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
Figure 118 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 119 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 120 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 121 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 122 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 123 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 124 MEA Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 125 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 126 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 127 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
Figure 128 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
Figure 129 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
Figure 130 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
Figure 131 MEA Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
Figure 132 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
Figure 133 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 134 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 135 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 136 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 137 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 138 Lonza: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 139 Lonza: R&D, 2021-2025 (US$ Million, AGR %)
Figure 140 Lonza: Regional Market Shares (%), 2025
Figure 141 Lonza: Business Segment Market Shares (%), 2025
Figure 142 Catalent, Inc. (A Novo Holdings Company): Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 143 Catalent, Inc. (A Novo Holdings Company): Regional Market Shares (%), 2024
Figure 144 Catalent, Inc. (A Novo Holdings Company): Business Segment Market Shares (%), 2024
Figure 145 AbbVie Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 146 AbbVie Inc.: R&D, 2021-2025 (US$ Million, AGR %)
Figure 147 AbbVie Inc.: Regional Market Shares (%), 2025
Figure 148 AbbVie Inc.: Business Segment Market Shares (%), 2025
Figure 149 Thermo Fisher Scientific Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 150 Thermo Fisher Scientific Inc.: R&D, 2021-2025 (US$ Million, AGR %)
Figure 151 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2025
Figure 152 Thermo Fisher Scientific Inc.: Business Segment Market Shares (%), 2025
Figure 153 Siegfried Holding AG: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 154 Siegfried Holding AG: Regional Market Shares (%), 2025
Figure 155 Siegfried Holding AG: Business Segment Market Shares (%), 2025
Figure 156 Evonik Industries AG: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 157 Evonik Industries AG: Regional Market Shares (%), 2025
Figure 158 Evonik Industries AG: Business Segment Market Shares (%), 2025
Figure 159 Boehringer Ingelheim International GmbH: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 160 Boehringer Ingelheim International GmbH: R&D, 2021-2025 (US$ Million, AGR %)
Figure 161 Boehringer Ingelheim International GmbH: Regional Market Shares (%), 2025
Figure 162 Boehringer Ingelheim International GmbH: Business Segment Market Shares (%), 2025
Figure 163 Piramal Pharma Solutions.: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 164 Piramal Pharma Solutions: Business Segment Market Shares (%), 2025
Figure 165 Samsung Biologics: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 166 WuXi AppTec: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 167 WuXi AppTec: Regional Market Shares (%), 2025
Figure 168 WuXi AppTec: Business Segment Market Shares (%), 2025
Figure 169 FUJIFILM Diosynth Biotechnologies: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 170 FUJIFILM Diosynth Biotechnologies: R&D, 2021-2024 (US$ Million, AGR %)
Figure 171 ICON plc: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 172 ICON plc: Regional Market Shares (%), 2024
Figure 173 Aenova Group: Net Revenue, 2021-2024 (US$ Million, AGR %)
Figure 174 Aenova Group: Regional Market Shares (%), 2024
Figure 175 Aenova Group: Business Segment Market Shares (%), 2024
Figure 176 Nipro Pharma Corporation: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 177 Nipro Pharma Corporation: R&D, 2021-2025 (US$ Million, AGR %)
Figure 178 Nipro Pharma Corporation: Regional Market Shares (%), 2025
Figure 179 Nipro Pharma Corporation: Business Segment Market Shares (%), 2025
Figure 180 Pfizer Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 181 Pfizer Inc.: R&D, 2021-2025 (US$ Million, AGR %)
Figure 182 Pfizer Inc.: Regional Market Shares (%), 2025
Figure 183 Pfizer Inc.: Business Segment Market Shares (%), 2025
Figure 184 Grifols, S.A.: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 185 Grifols, S.A.: R&D, 2021-2025 (US$ Million, AGR %)
Figure 186 Charles River Laboratories: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 187 Charles River Laboratories: Regional Market Shares (%), 2025
Figure 188 Charles River Laboratories: Business Segment Market Shares (%), 2025
Figure 189 IQVIA Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 190 IQVIA Inc.: Regional Market Shares (%), 2025
Figure 191 IQVIA Inc.: Business Segment Market Shares (%), 2025
Figure 192 Baxter: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 193 Baxter: R&D, 2021-2025 (US$ Million, AGR %)
Figure 194 Baxter: Regional Market Shares (%), 2025
Figure 195 Baxter: Business Segment Market Shares (%), 2025
Figure 196 Eurofins Scientific: Net Revenue, 2021-2025 (US$ Million, AGR %)
Figure 197 Nipro Pharma Corporation: Regional Market Shares (%), 2025
Figure 198 Eurofins Scientific: Business Segment Market Shares (%), 2025

List of Companies Profiled in the Report
AbbVie Inc.
Abnova Corporation
Aenova Group
Almac Group
Baxter
Boehringer Ingelheim International GmbH
Cambrex Corporation
Catalent, Inc. (A Novo Holdings company)
Charles River Laboratories
Curia Global, Inc.
Eurofins Scientific
Evonik Industries AG
FUJIFILM Diosynth Biotechnologies
Grifols, S.A.
ICON plc
IDT Biologika
IQVIA Inc.
Jubilant Pharmova Limited
Lannett
Lonza
Nipro Pharma Corporation
Pfizer Inc.
Piramal Pharma Solutions
Recipharm AB
Samsung Biologics
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Vetter Pharma
WuXi AppTec

List of Other Companies Mentioned in the Report
Adaptimmune
AGC Biologics
Ajinomoto Bio-Pharma Services
Akums Drugs & Pharmaceuticals
Ardena
Argenx
Axovia Therapeutics Ltd.
Axplora
Benuvia Operations
Bespak
BOOST Pharma
Bora Pharmaceuticals
BrickBio, Inc.
Cambrex
Captain T Cell
Carterra Inc.
Celonic Group
Cellares
Codis
Coriolis Pharma Research GmbH
CSL Limited
Delpharm
Eli Lilly and Company
ESTEVE CDMO
Fareva
Flamma Group
F. Hoffmann-La Roche Ltd.
Fresenius Kabi
Gaelic Laboratories Limited
Galapagos NV
Genbio
Hikal Ltd.
Hikma Pharmaceuticals
IntoCell Inc.
Johnson & Johnson
Kener
Kivu Bioscience
Laboratorios Farmacéuticos Rovi, S.A.
LegoChem Biosciences
LGM Pharma
LOTTE Biologics
LTS Lohmann
Lupin Limited
Matica Biotechnology
Meiji Seika Pharma Co., Ltd.
Meribel Pharma Solutions
MilliporeSigma
Mural Health Technologies, Inc.
Neolpharma
Neolsym
NewAmsterdam Pharma Company N.V.
NorthStar Medical Radioisotopes LLC
Olon S.p.A.
Ottimo Pharma
Plus Therapeutics
ProductLife Group (PLG)
Rarity PBC
Regis Technologies
ReiThera
Remedium Lifecare
Renaissance Lakewood CDMO
Rentschler Biopharma
RoslinCT
Sanofi
Sandoz Canada
Sharp Sterile
SillaJen
Siemens Healthineers
Simtra BioPharma
Siren Biotechnology
SK bioscience
SmartCella Holding AB
Sofinnova Partners
Sterling Pharma Solutions
Strides Pharma Global
Symbiosis Pharmaceutical Services
Teva Pharmaceutical Industries
Terumo Corporation
Tonix Pharmaceuticals Holding Corp.
TQ Therapeutics
Valo Health
Wilmington PharmaTech

List of Associations Mentioned in the Report
Active Pharmaceutical Ingredients Committee (APIC)
Association for Accessible Medicines (AAM)
BioPhorum (BPOG)
BioProcess Systems Alliance (BPSA)
Bulk Drug Manufacturers Association (BDMA)
Contract Pharma Association (CPA)
Drug, Chemical & Associated Technologies Association (DCAT)
European Fine Chemicals Group (EFCG)
Indian Drug Manufacturers’ Association (IDMA)
International Generic and Biosimilar Medicines Association (IGBA)
International Pharmaceutical Excipients Council (IPEC)
International Society for Pharmaceutical Engineering (ISPE)
Outsourced Pharma Association (OPA)
Parenteral Drug Association (PDA)
Pharmaceutical Contract Management Group (PCMG)

Industry Market Reports